← Alle mensen

CK

Christoph Kahl

7 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Individual Patient Data Meta-analyse of Consensus Molecular Subtypes as Biomarkers of Eerstelijns Behandeling in RAS ...
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026-01
Impact of sex on efficacy and safety of 1st-line treatment with FOLFIRI plus cetuximab or bevacizumab in RAS/BRAF wil...
European journal of cancer (Oxford, England : 1990) · 2026-01
Molecular hyperselection for optimal choice of eerstelijns targeted therapy independent of primary tumor sidedness: A...
European journal of cancer (Oxford, England : 1990) · 15 mei 2025
FOLFIRI with cetuximab or bevacizumab in RAS wild-type metastatic colorectal cancer: Refining eerstelijns treatment s...
European journal of cancer (Oxford, England : 1990) · 2 mei 2025
FOLFOXIRI plus cetuximab of bevacizumab bij BRAF V600E CRC: FIRE-4.5 fase II
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 september 2023
SNV's, TMB en MSI bij gemetastaseerd CRC: moleculaire analyse
European journal of cancer (Oxford, England : 1990) · 2020-09
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab bij gemetastaseerd colorectaal carcinoom: FIRE-3 post-hoc analyse
The Lancet. Oncology · 2016-10